Panavyr | Panavir vaginal suppositories 0.2 mg, 5 pcs.
Special Price
$46.56
Regular Price
$55.00
In stock
SKU
BID469679
Release form
Vaginal suppositories: cylindrical or cone-shaped, grayish-white, translucent.
Vaginal suppositories: cylindrical or cone-shaped, grayish-white, translucent.
Release form
Vaginal suppositories: cylindrical or cone-shaped, grayish-white, translucent.
Packaging
5 ml - bottles (2) - contour plastic packaging (1) - packs of cardboard.
Pharmacological action
Panavir - purified extract of the shoots of the plant Solanum tuberosum main active ingredient - hexose glycoside, consisting of glucose, ramnose, arabinose, mannose, xylose, galactose, uronic acids.
Panavir is an antiviral and immunomodulating agent. It increases the nonspecific resistance of the body to various infections and promotes the induction of interferon alpha and gamma by white blood cells.
At therapeutic doses, the drug is well tolerated.
Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic effects. In preclinical studies in laboratory animals, a negative effect on reproductive function and fetal development has not been established.
Has anti-inflammatory properties in experimental models of exudative edema, chronic proliferative inflammation, and in the pseudo-allergic inflammatory response test for A. concrnavalin.
An analgesic effect has been shown on models of neurogenic pain and pain caused by the inflammatory process and thermal irritation.
Has an antipyretic effect.
Neuroprotective properties are shown in a model of Parkinson's syndrome caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxin.
Has the ability to improve the functions of the retina and optic nerve.
It has wound healing properties in the conditions of a model of gastric ulcer.
Indications
As part of complex therapy of tick-borne encephalitis (reduction of viral load and removal of neurological symptoms, including anisoreflexia, decreased reflexes, soreness of exit points of cranial nerves, nystagmus).
As part of complex therapy: herpes virus infections of various localization (including recurrent genital herpes, Herpes zoster and ophthalmic herpes).
Decreased immunity in combination with infectious diseases.
Cytomegalovirus infection in combination with habitual miscarriage.
As part of complex therapy: papillomavirus infection (anogenital warts).
Contraindications
Severe kidney and spleen diseases, lactation, childhood, hypersensitivity to the herbal remedy.
Use during pregnancy and lactation
Use with caution in pregnancy. Contraindicated during lactation.
Special instructions
To prevent urogenital reinfection, simultaneous treatment of sexual partners is necessary. If there is no effect, the diagnosis should be confirmed.
Composition
Vaginal suppositories1 supp. active substance: Panavir (polysaccharides of Solanum tuberosum shoots) 200 mcg
Excipients: polyethylene oxide 1500 (macrogol 1500) - 1.2599 g polyethylene oxide 400 (macrogol 400) - 0.1399 g
Dosage and administration of
Intravaginally. Introduced into the vagina in the evening, as deep as possible, lying on your back with slightly bent legs, daily for 5 days, 1 vag. supp. A second course of treatment is possible after consulting a doctor.
Side effects
In rare cases, allergic reactions are possible.
If you experience any unwanted side effects or if other side effects are noted that are not listed in the instructions, you must stop administering the drug and consult your doctor.
Drug Interactions
Not registered.
Overdose
Overdose has not been reported. The results of preclinical studies indicate a low toxicity of the drug.
Storage Conditions
In a dark place at 2–25 РC.
Keep out of the reach and sight of children.
Shelf life
3 years.
Deystvuyushtee substance
Panavir
Terms and conditions otpuska IZ drugstore
prescription
dosage form
vaginal suppositories
Indications
Indications
Herpes zoster, HPV, Tick-borne encephalitis, Genital Herpes, Herpes
National Research Company, Russia
Vaginal suppositories: cylindrical or cone-shaped, grayish-white, translucent.
Packaging
5 ml - bottles (2) - contour plastic packaging (1) - packs of cardboard.
Pharmacological action
Panavir - purified extract of the shoots of the plant Solanum tuberosum main active ingredient - hexose glycoside, consisting of glucose, ramnose, arabinose, mannose, xylose, galactose, uronic acids.
Panavir is an antiviral and immunomodulating agent. It increases the nonspecific resistance of the body to various infections and promotes the induction of interferon alpha and gamma by white blood cells.
At therapeutic doses, the drug is well tolerated.
Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic effects. In preclinical studies in laboratory animals, a negative effect on reproductive function and fetal development has not been established.
Has anti-inflammatory properties in experimental models of exudative edema, chronic proliferative inflammation, and in the pseudo-allergic inflammatory response test for A. concrnavalin.
An analgesic effect has been shown on models of neurogenic pain and pain caused by the inflammatory process and thermal irritation.
Has an antipyretic effect.
Neuroprotective properties are shown in a model of Parkinson's syndrome caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxin.
Has the ability to improve the functions of the retina and optic nerve.
It has wound healing properties in the conditions of a model of gastric ulcer.
Indications
As part of complex therapy of tick-borne encephalitis (reduction of viral load and removal of neurological symptoms, including anisoreflexia, decreased reflexes, soreness of exit points of cranial nerves, nystagmus).
As part of complex therapy: herpes virus infections of various localization (including recurrent genital herpes, Herpes zoster and ophthalmic herpes).
Decreased immunity in combination with infectious diseases.
Cytomegalovirus infection in combination with habitual miscarriage.
As part of complex therapy: papillomavirus infection (anogenital warts).
Contraindications
Severe kidney and spleen diseases, lactation, childhood, hypersensitivity to the herbal remedy.
Use during pregnancy and lactation
Use with caution in pregnancy. Contraindicated during lactation.
Special instructions
To prevent urogenital reinfection, simultaneous treatment of sexual partners is necessary. If there is no effect, the diagnosis should be confirmed.
Composition
Vaginal suppositories1 supp. active substance: Panavir (polysaccharides of Solanum tuberosum shoots) 200 mcg
Excipients: polyethylene oxide 1500 (macrogol 1500) - 1.2599 g polyethylene oxide 400 (macrogol 400) - 0.1399 g
Dosage and administration of
Intravaginally. Introduced into the vagina in the evening, as deep as possible, lying on your back with slightly bent legs, daily for 5 days, 1 vag. supp. A second course of treatment is possible after consulting a doctor.
Side effects
In rare cases, allergic reactions are possible.
If you experience any unwanted side effects or if other side effects are noted that are not listed in the instructions, you must stop administering the drug and consult your doctor.
Drug Interactions
Not registered.
Overdose
Overdose has not been reported. The results of preclinical studies indicate a low toxicity of the drug.
Storage Conditions
In a dark place at 2–25 РC.
Keep out of the reach and sight of children.
Shelf life
3 years.
Deystvuyushtee substance
Panavir
Terms and conditions otpuska IZ drugstore
prescription
dosage form
vaginal suppositories
Indications
Indications
Herpes zoster, HPV, Tick-borne encephalitis, Genital Herpes, Herpes
National Research Company, Russia
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review